Taking Advantage of the Talent Pool

Several recent news articles have discussed the supersaturated status of the life sciences' postdoctoral trainee pool in the United States, but very few solutions to this inconceivable "problem" of too much talent have been proposed. Current postdoctoral scientists are often encouraged to abandon their professional desires to pursue "alternative careers" while undergraduate students are discouraged from pursuing research careers that require postgraduate training. These propositions not

Written byBuel Rodgers
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Several recent news articles have discussed the supersaturated status of the life sciences' postdoctoral trainee pool in the United States, but very few solutions to this inconceivable "problem" of too much talent have been proposed. Current postdoctoral scientists are often encouraged to abandon their professional desires to pursue "alternative careers" while undergraduate students are discouraged from pursuing research careers that require postgraduate training.

These propositions not only ignore the needs and desires of thousands of young scientists, but they also risk devaluing the greater perception of science and may create future disinterest. Conversely, taking advantage of this extraordinary human resource would promote immediate growth in all aspects of the scientific arena and could accelerate scientific and economic development equally.

Faced with a similar cache of talent, Japanese agencies have united in a massive effort to help faculty hopefuls and to bolster their country's biotechnology industry through the creation of novel ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies